Frianto Dedy, Setiawan Didik, Diantini Ajeng, Suwantika Auliya A
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia.
Faculty of Pharmacy, Universitas Buana Perjuangan, Karawang, Indonesia.
Int J Womens Health. 2022 Sep 12;14:1315-1322. doi: 10.2147/IJWH.S367953. eCollection 2022.
In countries with limited resources, a targeted HPV vaccination strategy by focusing in selected regions is preferable to be implemented than a nationwide vaccination strategy.
This study aimed to review articles on economic evaluations of HPV vaccination in countries over the world that applied targeted vaccination strategies.
Approximately 1769 articles were obtained from two databases (1242 and 527 articles from PubMed and ProQuest, respectively). The inclusion criteria in this systematic review were studies about full economic evaluations of HPV vaccination in targeted area or sub-national level and written in English. Full-text screening was applied to evaluate the eligibility. Final articles obtained were referred to the Consolidated Health Economic Evaluation Reporting Standard (CHEERS) checklist. Finally, we included only 4 articles that met all inclusion and exclusion criteria.
Included studies in this review focused in different targeted regions, such as Punjab State in India, Vientiane in Lao PDR, Southern Vietnam in Vietnam, and Brazilian Amazon in Brazil. From 24 criteria in the CHEERS checklist, all included studies could meet 21 criteria (87.5%). All included studies in this review applied modeling approaches, which can estimate the number of cases and treatment costs averted. Applying various settings, the results of this study showed that HPV vaccination could potentially reduce the number of cervical cancer cases by 20-72%. Taking cervical cancer screening into account, this study showed that targeted HPV vaccination was cost-effective or even cost-saving.
Implementation of HPV vaccination in sub-national level as the initial step before nationwide vaccination is more favorable to be implemented in countries with limited budget.
在资源有限的国家,实施聚焦特定区域的有针对性的人乳头瘤病毒(HPV)疫苗接种策略比全国性疫苗接种策略更可取。
本研究旨在综述世界各国应用有针对性的疫苗接种策略进行HPV疫苗接种经济评估的文章。
从两个数据库中获取了约1769篇文章(分别从PubMed和ProQuest获取1242篇和527篇文章)。本系统评价的纳入标准是关于在目标地区或国家以下层面进行HPV疫苗接种全面经济评估且用英文撰写的研究。应用全文筛选来评估 eligibility。获得的最终文章参照综合卫生经济评估报告标准(CHEERS)清单。最后,我们仅纳入了4篇符合所有纳入和排除标准的文章。
本综述纳入的研究聚焦于不同的目标地区,如印度的旁遮普邦、老挝万象、越南的越南南部以及巴西的巴西亚马逊地区。在CHEERS清单的24项标准中,所有纳入研究均符合21项标准(87.5%)。本综述中所有纳入研究均采用建模方法,该方法可估计避免的病例数和治疗成本。通过应用各种设定,本研究结果表明HPV疫苗接种可能使宫颈癌病例数减少20%至72%。考虑到宫颈癌筛查,本研究表明有针对性的HPV疫苗接种具有成本效益甚至可节省成本。
在预算有限的国家,在全国性疫苗接种之前先在国家以下层面实施HPV疫苗接种作为初始步骤更有利于实施。